SR 4233 (Tirapazamine): A New Anticancer Drug Exploiting Hypoxia in Solid Tumours

British Journal of Cancer- United Kingdom

doi 10.1038/bjc.1993.220

Full Text

Abstract

Available in

Date

Authors

Publisher

Springer Science and Business Media LLC

Related search

The Effect of Tirapazamine (SR-4233) Alone or Combined With Chemotherapeutic Agents on Xenografted Human Tumours

British Journal of Cancer
Cancer ResearchOncology
1996English

Exploiting Tumor Hypoxia in the Treatment of Solid Tumors.

Thermal Medicine(Japanese Journal of Hyperthermic Oncology)
2001English

Diacetoxyscirpenol as a New Anticancer Agent to Target Hypoxia-Inducible Factor 1

Oncotarget
Oncology
2016English

A Quantitative in Silico Platform for Simulating Cytotoxic and Nanoparticle Drug Delivery to Solid Tumours

Interface Focus
BiochemistryBiophysicsBiomaterialsBioengineeringBiotechnologyBiomedical Engineering
2019English

Hypoxia Selective DNA Alkylating Analogs of Tirapazamine and Ap-Derived DNA Interstrand Cross-Links||Hypoxia Selective DNA Alkylating Analogs of Tirapazamine and Ap-Derived DNA Interstrand Cross-Links

English

Immunohistochemical Detection of a Hypoxia Marker in Spontaneous Canine Tumours

British Journal of Cancer
Cancer ResearchOncology
1990English

The Extravascular Penetration of Tirapazamine Into Tumours: A Predictive Model of the Transport and Efficacy of Hypoxia Specific Cytotoxic Analogues and the Potential Use of Cucurbiturils to Facilitate Delivery

International Journal of Computational Biology and Drug Design
Drug DiscoveryComputer Science Applications
2017English

The Effect of Anticancer Therapy on Anti-Hepatitis B Antibody Titres in Patients With Haematological Malignancies and Solid Tumours

Journal of International Medical Research
BiochemistryMedicineCell Biology
2016English

The Buckling of Capillaries in Solid Tumours

Proceedings of the Royal Society A: Mathematical, Physical and Engineering Sciences
MathematicsEngineeringAstronomyPhysics
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy